Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.070
-0.010 (-0.25%)
At close: Oct 30, 2024, 4:00 PM
4.090
+0.020 (0.49%)
After-hours: Oct 30, 2024, 7:13 PM EDT
Prime Medicine Revenue
Prime Medicine had revenue of $591.00K in the twelve months ending June 30, 2024.
Revenue (ttm)
$591.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
$2,526
Employees
234
Market Cap
518.14M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | 5.21M | - | - |
Dec 31, 2019 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Community Health Systems | 12.55B |
Emergent BioSolutions | 1.10B |
Varex Imaging | 832.70M |
Arcturus Therapeutics Holdings | 163.87M |
Surmodics | 120.82M |
Sage Therapeutics | 97.24M |
Cartesian Therapeutics | 54.10M |
PRME News
- 6 days ago - Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson's Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress - GlobeNewsWire
- 15 days ago - Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson's Disease, at Upcoming Scientific Meetings - GlobeNewsWire
- 4 weeks ago - Crude Oil Moves Higher; Prime Medicine Shares Spike Higher - Benzinga
- 4 weeks ago - Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline - Benzinga
- 4 weeks ago - Prime Medicine Unveils Strategically Focused Pipeline - GlobeNewsWire
- 6 months ago - Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire
- 6 months ago - Alphabet Bought Up Two Slumping Stocks - Barrons
- 6 months ago - Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire